Baybiosciences · Newsroom
The Growing Demand for High-Quality Liver Disease Biospecimens in Clinical Trials
The demand for high-quality liver disease biospecimens is rapidly increasing as clinical trials expand, driving innovation in drug development and biomarker discovery.April 1, 2026